investment by the NIH in prevention totaled almost $2 billion. Two major newspapers, the Washington Post and the New York Times, reporting on the president's budget for the NIH, pointed out that the budget proposes to cut funding for the number one killer, heart disease, and that stroke funding would be cut.
The AHA has been working on all fronts to obtain more resources for cardiovascular and stroke research at the NIH. Shortly after the presidential election, the AHA activated its Grassroots Science Network, composed of the executive committees of the AHA Science Councils, and the Federal Legislative Grassroots Network to write President-elect Clinton and urge him to make research for cardiovascular diseases, including heart attack and stroke, a top priority in his fiscal year 1994 budget. The AHA also encouraged members of the Mended Hearts and the Courage Stroke Network to write to the president.
As part of the AHA's efforts to increase federal funding for biomedical research, on January 7, AHA President Edward S. Cooper, MD, held annual meetings with the NIH director and the directors of the NHLBI, NINDS, and the National Institute on Aging. In March, the AHA secured report language in House Concurrent Resolution 64, establishing nonbinding congressional budgets for fiscal years 1994 through 1998, that recognizes the seriousness of cardiovascular diseases, including heart attack and stroke, and assumes a significant increase in funding for research in these diseases. The AHA was also instrumental in adding language covering cardiovascular diseases in report language that assumes a substantial increase in funding for women's health research and disease screening and prevention.
Before The AHA has a well-established grassroots network, with 56 affiliates nationwide and science council members throughout the country. Unfortunately, the documented rates of response by AHA volunteers to the AHA Alerts have been anemic, ranging from single digits to a high of 20%. As a member of the cardiovascular community, you can play a pivotal role in influencing federal biomedical research issues.
Personal contact with your US senator or representative is an effective way to promote the cause of biomedical research.
